Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramirez-Lassepas, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramirez-Lassepas, M.
NEUROLOGY 1981;31:316
© 1981 American Academy of Neurology

Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysm

Manuel Ramirez-Lassepas, M.D.

From the University of Minnesota, Minneapolis, and St Paul-Ramsey Medical Center, St Paul, MN.

There are 25 published studies on the treatment with antifibrinolytic agents of subarachnoid hemorrhage (SAH) caused by ruptured intracranial aneurysm. Twelve of these studies were uncontrolled and, except for one, all reported reduced incidence of rebleeding. Of 13 controlled studies, 9 were randomized, and 3 were also double-blind. In 7, reported decrease in rebleeding was reported, but only 4 showed decreased mortality. Three studies showed no effect, and three reported a higher incidence of rebleeding in treated patients. Discrepancies may be due to the multiple clinical variables of SAH and to flaws in methodology; nevertheless, the data fail to demonstrate that antifibrinolytic therapy alters the natural history of the disease.

Address correspondence and reprint requests to Dr Ramirez-Lassepas, Department of Neurology, St Paul-Ramsey Medical Center, 640 Jackson Street, St Paul, MN 55101

This work was supported in part by the by the St Paul-Ramsey Hospital Medical Education and Research Foundation

Accepted for publication June 2, 1980.




This article has been cited by other articles:


Home page
Arch NeurolHome page
R. A. Solomon and M. E. Fink
Current Strategies for the Management of Aneurysmal Subarachnoid Hemorrhage
Arch Neurol, July 1, 1987; 44(7): 769 - 774.
[Abstract] [PDF]


Home page
Arch NeurolHome page
H. P. Adams Jr
Antifibrinolytics in Aneurysmal Subarachnoid Hemorrhage: Do They Have a Role? Maybe
Arch Neurol, January 1, 1987; 44(1): 114 - 115.
[Abstract] [PDF]


Home page
Arch NeurolHome page
B. Weir
Antifibrinolytics in Subarachnoid Hemorrhage: Do They Have a Role? No
Arch Neurol, January 1, 1987; 44(1): 116 - 118.
[Abstract] [PDF]


Home page
Arch NeurolHome page
H. P. Adams Jr, A. L. Sahs, and J. Torner
Antifibrinolytic Therapy-Reply
Arch Neurol, June 1, 1982; 39(6): 384 - 384.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by AAN Enterprises, Inc.